Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Variegate porphyria]

J Arata1

  • 1Department of Dermatology Okayama University Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Variegate porphyria, a rare genetic disorder, was reviewed for its epidemiology, clinical signs, and biochemistry. The review also covered dual porphyrias, highlighting key aspects of these related conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of giant congenital melanocytic nevi with cultured epithelial autografts: Clinical and histopathological analysis.

Regenerative therapy·2021
Same author

Lichen planus pemphigoides and multiple keratoacanthomas associated with colon adenocarcinoma.

The British journal of dermatology·2004
Same author

Replantation of multi-level fingertip amputation using the pocket principle (palmar pocket method).

British journal of plastic surgery·2003
Same author

[Azithromycin in the field of dermatology].

The Japanese journal of antibiotics·2003
Same author

Amelioration of prolidase deficiency in fibroblasts using adenovirus mediated gene transfer.

The Japanese journal of human genetics·2002
Same author

Amicrobial pustular dermatosis in two patients with immunological abnormalities.

Clinical and experimental dermatology·2002
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Epidemiology

Background:

  • Variegate porphyria (VP) is a rare autosomal dominant disorder.
  • VP is characterized by a deficiency in the enzyme protoporphyrinogen oxidase (PPOX).

Observation:

  • This review examines the epidemiological, clinical, and biochemical facets of VP.
  • The study also addresses dual porphyrias, which involve concurrent deficiencies in multiple heme biosynthesis enzymes.

Findings:

  • Epidemiological data on VP prevalence and incidence were compiled.
  • Clinical manifestations and biochemical markers associated with VP were detailed.
  • The review provides insights into the pathophysiology and genetic basis of VP and dual porphyrias.

Implications:

Related Experiment Videos

  • Understanding VP and dual porphyrias aids in diagnosis and management.
  • This review contributes to the knowledge base for rare metabolic disorders.
  • Further research into PPOX enzyme function and therapeutic strategies is warranted.